Previous 10 | Next 10 |
Total revenue for the first quarter of 2023 was approximately $0.91 million, an increase of approximately 94% compared to the first quarter of 2022 Expanded U.S. growth opportunities with the Unyvero UTI De Novo FDA submission and Unyvero distribution partnership with Fisher Healt...
2023-05-14 17:35:54 ET Major earnings expected after the bell on Monday include: Danaos Corporation ( DAC ) Canoo ( GOEV ) Arrival ( ARVL ) Cara Therapeutics ( CARA ) Fortuna Silver Mines ( FSM ) For further details see: Notable earnings a...
ROCKVILLE, Md., May 08, 2023 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ: OPGN) (“OpGen” or “the Company”) announced today that the Company will provide a business update and report its first quarter 2023 financial results after the close of the U.S. financial markets on M...
ROCKVILLE, Md., May 04, 2023 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN, “OpGen” or “the Company”), a precision medicine company harnessing the power of molecular diagnostics and bioinformatics to help combat infectious disease, today announced the closing of its pr...
2023-05-02 05:17:45 ET OpGen ( NASDAQ: OPGN ) price a common stock and warrants offering to raise $3.5M in gross proceeds. The company is offering ~4.5M common shares (or pre-funded warrants in lieu) and warrants to buy up to ~4.5M shares at a combined price of $0.7785 pe...
ROCKVILLE, Md., May 01, 2023 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN, “OpGen” or “the Company”), a precision medicine company harnessing the power of molecular diagnostics and bioinformatics to help combat infectious disease, today announced the pricing of a publ...
2023-04-27 07:30:23 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips The biggest pre-market stock movers are ready to go as we dive into the latest news traders need to know about on Thursday! Moving stocks this morning are earnings reports, clinical trial n...
Triggers milestone payment of approxi mately $0.3 million ROCKVILLE, Md., April 26, 2023 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN, “OpGen” or “the Company”), a precision medicine company harnessing the power of molecular diagnostics and bioinformatics...
2023-04-18 17:37:57 ET OpGen ( NASDAQ: OPGN ) on Tuesday said it had entered into a distribution agreement for its diagnostic platform with Fisher Healthcare, a part of Thermo Fisher Scientific ( TMO ). OPGN stock jumped 17.1% to $1.23 after hours. As per the deal,...
Fisher Healthcare, a part of Thermo Fisher Scientific, will become the non-exclusive national laboratory distribution partner alongside OpGen, Inc.’s direct sales in the U.S. for the Unyvero A50 platform Initial focus on FDA cleared Unyvero LRT (BAL) cartridges for hospitalized pne...
News, Short Squeeze, Breakout and More Instantly...
Windtree Therapeutics Inc. (WINT) is expected to report for Q1 2024 CohBar Inc. (CWBR) is expected to report for Q1 2024 hopTo Inc (HPTO) is expected to report for Q1 2024 Bitech Technologies Corporation (BTTC) is expected to report for Q1 2024 Roadzen Inc. (RDZN) is expected to r...
Gelesis Holdings, Inc. (GLSHQ) is expected to report for Q1 2024 EVmo Inc (YAYO) is expected to report for Q1 2024 Chiba Bank Ltd. ADR (CHBAY) is expected to report for Q4 2024 Spark Networks SE (LOVLQ) is expected to report for Q1 2024 ToughBuilt Industries Inc. (TBLT) is expecte...